Search research articles
Contact Us
Filters
Showing results (11-20 of 85) with videos related to
Page
of 9
Sort By:
Seminars in Cancer Biology
|
February 12, 2020
Turning liabilities into opportunities: Off-target based drug repurposing in cancer
Vinayak Palve, Yi Liao, Lily L Remsing Rix, et al.
Chembiochem : a European Journal of Chemical Biology
|
January 4, 2003
Urdamycin L: a novel metabolic shunt product that provides evidence for the role of the urdM gene in the urdamycin A biosynthetic pathway of Streptomyces fradiae TU 2717
Uwe Rix, Lily L Remsing, Dirk Hoffmeister, et al.
Journal of Proteome Research
|
November 23, 2017
Comparison of Quantitative Mass Spectrometry Platforms for Monitoring Kinase ATP Probe Uptake in Lung Cancer
Melissa A Hoffman, Bin Fang, Eric B Haura, et al.
Plos Computational Biology
|
December 3, 2010
A computational approach to analyze the mechanism of action of the kinase inhibitor bafetinib
Thomas R Burkard, Uwe Rix, Florian P Breitwieser, et al.
Journal of the American Chemical Society
|
April 9, 2004
The dynamic structure of jadomycin B and the amino acid incorporation step of its biosynthesis
Uwe Rix, Jianting Zheng, Lily L Remsing Rix, et al.
ACS Chemical Biology
|
September 22, 2015
Chemoproteomics Reveals Novel Protein and Lipid Kinase Targets of Clinical CDK4/6 Inhibitors in Lung Cancer
Natalia J Sumi, Brent M Kuenzi, Claire E Knezevic, et al.
Journal of Proteome Research
|
August 6, 2009
Acid elution and one-dimensional shotgun analysis on an Orbitrap mass spectrometer: an application to drug affinity chromatography
Nora V Fernbach, Melanie Planyavsky, André Müller, et al.
The Journal of Antibiotics
|
September 15, 2005
Cytotoxic activities of new jadomycin derivatives
Jian-Ting Zheng, Uwe Rix, Lixia Zhao, et al.
Molecular Cancer Therapeutics
|
November 15, 2017
Ceritinib Enhances the Efficacy of Trametinib in <i>BRAF/NRAS</i>-Wild-Type Melanoma Cell Lines
Daniel Verduzco, Brent M Kuenzi, Fumi Kinose, et al.
Biochemical Pharmacology
|
August 22, 2007
Selective serotonin reuptake inhibitors--a new modality for the treatment of lymphoma/leukaemia?
Christian Schuster, Nora Fernbach, Uwe Rix, et al.
Page
of 9
Search research articles
Search
Showing results (11-20 of 85) with videos related to
Sort By:
Page
of 9
Seminars in Cancer Biology
|
February 12, 2020
Turning liabilities into opportunities: Off-target based drug repurposing in cancer
Vinayak Palve, Yi Liao, Lily L Remsing Rix, et al.
Chembiochem : a European Journal of Chemical Biology
|
January 4, 2003
Urdamycin L: a novel metabolic shunt product that provides evidence for the role of the urdM gene in the urdamycin A biosynthetic pathway of Streptomyces fradiae TU 2717
Uwe Rix, Lily L Remsing, Dirk Hoffmeister, et al.
Journal of Proteome Research
|
November 23, 2017
Comparison of Quantitative Mass Spectrometry Platforms for Monitoring Kinase ATP Probe Uptake in Lung Cancer
Melissa A Hoffman, Bin Fang, Eric B Haura, et al.
Plos Computational Biology
|
December 3, 2010
A computational approach to analyze the mechanism of action of the kinase inhibitor bafetinib
Thomas R Burkard, Uwe Rix, Florian P Breitwieser, et al.
Journal of the American Chemical Society
|
April 9, 2004
The dynamic structure of jadomycin B and the amino acid incorporation step of its biosynthesis
Uwe Rix, Jianting Zheng, Lily L Remsing Rix, et al.
ACS Chemical Biology
|
September 22, 2015
Chemoproteomics Reveals Novel Protein and Lipid Kinase Targets of Clinical CDK4/6 Inhibitors in Lung Cancer
Natalia J Sumi, Brent M Kuenzi, Claire E Knezevic, et al.
Journal of Proteome Research
|
August 6, 2009
Acid elution and one-dimensional shotgun analysis on an Orbitrap mass spectrometer: an application to drug affinity chromatography
Nora V Fernbach, Melanie Planyavsky, André Müller, et al.
The Journal of Antibiotics
|
September 15, 2005
Cytotoxic activities of new jadomycin derivatives
Jian-Ting Zheng, Uwe Rix, Lixia Zhao, et al.
Molecular Cancer Therapeutics
|
November 15, 2017
Ceritinib Enhances the Efficacy of Trametinib in <i>BRAF/NRAS</i>-Wild-Type Melanoma Cell Lines
Daniel Verduzco, Brent M Kuenzi, Fumi Kinose, et al.
Biochemical Pharmacology
|
August 22, 2007
Selective serotonin reuptake inhibitors--a new modality for the treatment of lymphoma/leukaemia?
Christian Schuster, Nora Fernbach, Uwe Rix, et al.
Page
of 9